Professor & Chief,
Division of Transplant Surgery
Support the Transplant Surgery Program in the quest to discover new treatments for diseases of the kidney, liver and pancreas and to improve transplantation outcomes.
The Annual Conference at The Siverado in Napa features an outstanding group of faculty, led by Francis Y.K. Yao, M.D., discussing the latest developments in liver transplantation and liver disease.
Holger Willenbring, M.D., Ph.D., and researchers from his lab show that cholangiocarcinomas, also known as bile duct cancers, may actually develop when one type of liver cell morphs into a totally different type, a process scientists used to consider all but impossible.
The Division of Transplant Surgery has a thriving research program with a broad portfolio of clinical trials. These are led by Principal Investigators (PI) conducting research to support advances in treatment, supported by a professional staff of trial coordinators and clinical research nurses. Below is a list of active trials including enrollment status and contact information for the study.